We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
+1.96%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
–
AUM
$25.3B
AUM Growth
+$814M
Cap. Flow
+$613M
Cap. Flow %
2.42%
Top 10 Hldgs %
16.08%
Holding
3,081
New
5
Increased
1,358
Reduced
932
Closed
769

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$31.9M
2
AAPL icon
Apple
AAPL
+$24.9M
3
T icon
AT&T
T
+$21.1M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$20.2M
5
BIIB icon
Biogen
BIIB
+$19.7M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$34M
2
RHT
Red Hat Inc
RHT
+$22.2M
3
HSBC icon
HSBC
HSBC
+$20.3M
4
APC
Anadarko Petroleum
APC
+$19.9M
5
CAJ
Canon, Inc.
CAJ
+$16.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Financials 16.76%
3 Healthcare 12.56%
4 Consumer Discretionary 10.05%
5 Communication Services 8.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BRK.A icon
401
Berkshire Hathaway Class A
BRK.A
$1.1T
$13.1M 0.05%
42
+5
+14% +$1.55M
KLAC icon
402
KLA
KLAC
$222B
$13M 0.05%
816,570
-20,600
-2% -$288K
ZBH icon
403
Zimmer Biomet
ZBH
$18.8B
$12.9M 0.05%
97,110
+3,916
+4% +$506K
GWW icon
404
W.W. Grainger
GWW
$64.2B
$12.9M 0.05%
43,421
+3,331
+8% +$926K
DHI icon
405
D.R. Horton
DHI
$41.2B
$12.9M 0.05%
244,368
+5,565
+2% +$266K
NTRS icon
406
Northern Trust
NTRS
$21.8B
$12.8M 0.05%
137,528
+3,207
+2% +$295K
E icon
407
ENI
E
$78B
$12.8M 0.05%
420,397
-101,589
-19% -$3.14M
KEYS icon
408
Keysight
KEYS
$50.7B
$12.8M 0.05%
131,635
-4,471
-3% -$414K
CMA
409
DELISTED
Comerica
CMA
$12.8M 0.05%
193,986
-14,845
-7% -$983K
UBS icon
410
UBS Group
UBS
$170B
$12.8M 0.05%
1,130,939
+217,508
+24% +$2.45M
ALC icon
411
Alcon
ALC
$34B
$12.7M 0.05%
218,510
+2,600
+1% +$156K
SU icon
412
Suncor Energy
SU
$77.7B
$12.7M 0.05%
402,158
+1,132
+0.3% +$34K
NMR icon
413
Nomura Holdings
NMR
$28.3B
$12.7M 0.05%
2,984,587
+640,293
+27% +$2.43M
AKAM icon
414
Akamai
AKAM
$15.6B
$12.6M 0.05%
138,362
+4,725
+4% +$410K
MNST icon
415
Monster Beverage
MNST
$95.1B
$12.6M 0.05%
433,976
-8,900
-2% -$270K
CE icon
416
Celanese
CE
$4.82B
$12.6M 0.05%
102,875
+16,652
+19% +$1.88M
WMB icon
417
Williams Companies
WMB
$85.8B
$12.6M 0.05%
522,179
-87,390
-14% -$2.2M
OXY icon
418
Occidental Petroleum
OXY
$55.7B
$12.5M 0.05%
281,487
+99,914
+55% +$4.72M
CTAS icon
419
Cintas
CTAS
$86.6B
$12.5M 0.05%
186,068
+12,820
+7% +$821K
CEO
420
DELISTED
CNOOC Limited
CEO
$12.4M 0.05%
81,772
-7,031
-8% -$1.11M
GRMN
421
Garmin
GRMN
$56.9B
$12.4M 0.05%
146,880
-3,414
-2% -$275K
MTB icon
422
M&T Bank
MTB
$36.3B
$12.3M 0.05%
77,845
-5,994
-7% -$943K
TECK icon
423
Teck Resources
TECK
$28.2B
$12.2M 0.05%
754,225
-19,435
-3% -$367K
AME icon
424
Ametek
AME
$53.9B
$12.2M 0.05%
132,545
+17,228
+15% +$1.52M
PHI icon
425
PLDT
PHI
$4.31B
$12.1M 0.05%
549,387
+32,787
+6% +$733K
15 16
17
18 19

Similar funds

OU
Optiver US Chicago, Illinois $50B AUM 53.51% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
GAM
Greenwoods Asset Management Grand Cayman, Cayman Islands $4.35B AUM 149.74% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
SWM
SVA Wealth Management Madison, Wisconsin $1.15B AUM 22.3% 1-Year Est. Return
LCM
Lomas Capital Management New York $1.04B AUM 24.59% 1-Year Est. Return
HCMNY
Howard Capital Management (New York) New York $891M AUM 34.82% 1-Year Est. Return
BII
Bainco International Investors Boston, Massachusetts $873M AUM 30.2% 1-Year Est. Return

Aperio Group's Q3 2019 Portfolio in Review

As of Q3 2019, Aperio Group held 3,081 positions worth $25.3B, up 3.3% from $24.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Aperio Group's Q3 2019 filing shows 5 new, 1,358 increased, 932 reduced and 769 closed positions. Its largest new stake was Genmab: 211,272 shares worth $4.28M. The largest sale was Pfizer, an estimated $34M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Aperio Group's largest Q3 2019 buy was Genmab: 211,272 shares worth $4.28M.
  • Aperio Group added most to Microsoft in Q3 2019, an estimated $31.9M increase.
  • Aperio Group's biggest Q3 2019 reduction was Pfizer, cutting an estimated $34M.
  • Aperio Group fully exited Red Hat Inc in Q3 2019, selling an estimated $22.2M.
  • Aperio Group's ten largest holdings make up 16% of its $25.3B portfolio in Q3 2019.
  • Aperio Group opened 5 new positions and closed 769 in Q3 2019.
  • Aperio Group's portfolio value rose 3.3% quarter-over-quarter to $25.3B.

Based on Aperio Group's 13F filing for Q3 2019, filed 6 Nov 2019.